2/27
09:34 am
pfsa
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering [Yahoo! Finance]
Medium
Report
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering [Yahoo! Finance]
2/27
09:15 am
pfsa
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
Medium
Report
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
2/19
08:30 am
pfsa
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
High
Report
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
2/14
01:32 am
pfsa
Low
Report
2/13
08:30 am
pfsa
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
High
Report
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
2/12
04:30 pm
pfsa
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
High
Report
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
2/5
08:00 am
pfsa
Profusa Announces 1-for-75 Reverse Stock Split
High
Report
Profusa Announces 1-for-75 Reverse Stock Split
1/29
08:00 am
pfsa
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
High
Report
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
1/16
07:30 am
pfsa
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
Medium
Report
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
1/8
07:42 am
pfsa
Profusa Adds Leading Greek Vascular Surgeon to Customer Base [Yahoo! Finance]
Low
Report
Profusa Adds Leading Greek Vascular Surgeon to Customer Base [Yahoo! Finance]
1/8
07:30 am
pfsa
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
Medium
Report
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
12/31
09:22 am
pfsa
Profusa Bolsters European Commercial Network with New French Distributor, MedSell [Yahoo! Finance]
Medium
Report
Profusa Bolsters European Commercial Network with New French Distributor, MedSell [Yahoo! Finance]
12/31
07:30 am
pfsa
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
Low
Report
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
12/30
07:07 pm
pfsa
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 [Yahoo! Finance]
Medium
Report
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 [Yahoo! Finance]
12/30
04:14 pm
pfsa
Profusa (NASDAQ:PFSA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
Profusa (NASDAQ:PFSA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/15
07:46 am
pfsa
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 [Yahoo! Finance]
High
Report
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 [Yahoo! Finance]
12/15
07:30 am
pfsa
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025
High
Report
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025
12/11
09:13 am
pfsa
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 [Yahoo! Finance]
Low
Report
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 [Yahoo! Finance]
12/11
08:30 am
pfsa
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026
Low
Report
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026